Vaginal treatments
- 11 Dec 2023
- 2 Minutes to read
- Print
- PDF
Vaginal treatments
- Updated on 11 Dec 2023
- 2 Minutes to read
- Print
- PDF
Article summary
Did you find this summary helpful?
Thank you for your feedback
1. VAGINAL MOISTURISERS
- Vaginal moisturisers can, in some individuals, offer relief from symptoms of vaginal dryness.
- These should be used regularly, for example daily, and not just before intercourse.
- Options include YES, SYLK and Regelle. These are available on prescription and are less likely to cause irritation compared to some other over the counter preparations.
- Simple emollients such as Epaderm and Cetraben may be helpful.
- Hyalofemme contains hyaluronic acid, which may help dryness.
2. VAGINAL LUBRICANTS
- Vaginal lubricants are intended for use with sexual or any penetrative activity.
- Women should be advised that oil-based lubricants can have a negative impact on condom integrity.
- Options include YES and SYLK (lubricant versions).
3. OSPEMIFENE
- Ospemifene is a selective oestrogen receptor modulator that has an oestrogen like effect in the vagina.
- Pre-clinical data indicates that Ospemifene acts as an agonist in the vagina, partial agonist in the uterus and agonist in the bone while having a neutral to antagonist effect in the breast.
- Its indication is for moderate to severe vulval and vaginal atrophy in post-menopausal women who are not candidates for local vaginal oestrogen.
- NICE says consider ospemifene as an oral treatment option for troublesome genitourinary menopause symptoms, if locally applied treatments are impractical, for example, because of disability.
- It does not appear to have any negative effects on the endometrium or be associated with an increased risk of thromboembolism.
- The commonest side effect is hot flushes, which are usually transient.
- Ospemifene should not be used in women with known or suspected breast cancer because the drug has not been adequately studied in this group.
- Specialist initiation may be required.
4. LASER TREATMENTS
- Although some studies are promising, the long-term efficacy and safety of laser treatments are lacking and there is potential for harm, for example in the form of scarring.
- NICE says do not offer vaginal laser treatment for troublesome genitourinary menopause symptoms unless as part of a randomised controlled trial.
5. GENERAL ADVICE
Perfumes, powders, soaps, deodorants, panty liners, spermicides and many brands of lubricants often contain irritant compounds and women should be advised to avoid these.
Note:
Ideal moisturisers and lubricants should be body similar in terms of pH and osmolality. WHO recommends that a vaginal lubricant should have a pH of about 4.5 and ideally, the osmolality of a personal lubricant should not exceed 380 mOsm/Kg and definitely not 1200 mOsm/Kg. The normal osmolality of female vaginal secretions is 260–290 mOsm/kg.
References and Further Information:
- Simon J, Ferenczy A, Black D et al. Efficacy, tolerability and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis. Menopause 2023.
- Edwards D and Panay N. Treating vulvovaginal atrophy /genitoruinary syndrome of menopause: how important is vaginal lubricant and moisturiser composition. Climacteric 2016.
- Use and procurement of additional lubricants for male and female condoms: WHO/UNFPA/FHI360. Advisory note.
- NAMS position statement. The 2020 genitourinary syndrome of menopause statement of The North American Menopause Society. The Journal of the North American Menopause Society. Vol 27 (9). 2020. Page 983.
- Archer D, Simon J, Portman D et al. Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause. Expert review of Endocrinology and Metabolism. 2019.
- National Institute for Health and Care Excellence. Guideline. Menopause (update). Draft for consultation, Nov 2023.
Was this article helpful?